作者: Michael Stock , Florian Otto
DOI: 10.1016/J.GENE.2005.06.026
关键词:
摘要: Despite its decreasing frequency in the Western world during recent decades, gastric cancer is still one of leading causes cancer-related deaths worldwide. Due to oligosymptomatic course early cancer, most cases are diagnosed advanced stages disease. The curative potential current standard treatment continues be unsatisfactory, despite multimodal approaches involving surgery, chemotherapy and radiotherapy. Novel therapeutics including small molecules monoclonal antibodies being developed have been partially introduced into clinical use connection with neoplastic diseases such as chronic myeloid leukemia, non-Hodgkin's lymphoma colorectal cancer. Thorough understanding changes gene expression occurring carcinogenesis may help develop targeted therapies improve this molecular biology techniques generated a wealth data on up- down-regulation, activation inhibition specific pathways Here, we provide an overview different aspects aberrant patterns